Searchable abstracts of presentations at key conferences in endocrinology

ea0034p214 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Chemerin as a potential screening marker for sub-clinical diabetes?

Fatima Syeda Sadia , Iqbal Najeeha Talat

Objective: Chemerin a novel adipokine; affects the lipid and glucose homeostasis along with adipose tissue metabolism. Elevated levels of peptide have shown to be associated with disruption of normal insulin function and systemic inflammation, which also results in hyperglycemia in clinical diabetes. This study aims to identify whether chemerin in conjunction with TNFα and hsCRP can act as screening marker to identify subclinical diabetes.Methods: F...